Sleep Disorders Clinical Trial
Official title:
Sleep Length and Circadian Regulation in Humans
This research will examine why sleep restriction reduces the body clock's response to bright light. The results will enable the optimization of the bright light treatment of people who suffer from circadian rhythm sleep disorders, which include shift work sleep disorder, jet lag, delayed sleep phase syndrome and winter depression, thereby improving public health and safety, well-being, mood, mental function, and quality of life.
Millions of Americans suffer from circadian rhythm sleep disorders, which include shift work
sleep disorder, jet lag, delayed sleep phase syndrome and possibly winter depression. These
conditions are typically characterized by persistent insomnia and/or excessive daytime
sleepiness, impaired performance, and gastrointestinal distress. These negative symptoms
result from a misalignment between the timing of the external social world and the timing of
the internal circadian (body) clock. Circadian rhythm sleep disorders are effectively
treated with bright light, which phase shifts the circadian clock, thereby realigning it
with the timing of the external social world.
It is widely recognized that social influences have led to an increasing prevalence of sleep
restriction in modern society. We recently demonstrated for the first time that short sleep
episodes, when compared to long sleep episodes, markedly reduce phase advances to bright
light. Thus when people cut their sleep short, they inadvertently reduce their circadian
responsiveness to bright light. The mechanism(s) behind these reduced phase shifts to light
are unknown. However, there are at least two aspects of short sleep episodes that could be
responsible for this effect. First, short sleep episodes are associated with partial sleep
deprivation. Second, as humans sleep with their eyes closed and are usually exposed to light
when awake, short sleep episodes are also associated with short dark lengths. Our overall
goal is to determine the biobehavioral mechanisms by which short sleep episodes impair phase
shifts to bright light. Specific Aim 1 is to determine the effect of partial sleep
deprivation on phase advances to light, while controlling for dark length. Specific Aim 2 is
to determine the effect of short dark lengths on phase advances to light while minimizing
sleep deprivation. We will estimate the timing of the human circadian clock by measuring
salivary melatonin, a neuroendocrine hormone released from the pineal gland, and collecting
measures of sleep via actigraphy, and sleepiness, mood, gastrointestinal distress and
cognitive performance via computerized assessment.
Characterization of the separate effects of sleep deprivation and dark length on circadian
phase shifts to light in humans is critical to understanding how humans respond to light
during their daily life activities. Furthermore, the findings of this research will produce
important and practical recommendations for avoiding decrements to phase shifts to light,
thereby optimizing the bright light treatment of circadian rhythm sleep disorders, and thus
improving public health and safety, well-being, mood, cognitive function, and quality of
life.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Single Blind (Subject), Primary Purpose: Basic Science
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02188498 -
Electrocardiography Data Analysis in Sleep Disorders
|
||
Completed |
NCT00990106 -
Augmentation Trial of Prazosin for Post-Traumatic Stress Disorder (PTSD)
|
N/A | |
Completed |
NCT00942253 -
Exercise Training in Dialysis Patients With Restless Legs Syndrome (RLS)
|
Phase 2 | |
Completed |
NCT00163670 -
The Impact of Sleep Disorders on Motor Vehicle Accidents
|
N/A | |
Completed |
NCT00256685 -
Study Evaluating DVS-233 SR to Treat Vasomotor Systems Associated With Menopause
|
Phase 3 | |
Completed |
NCT00203827 -
Pediatric Sleep Questionnaire: Use for Collection of Clinical Data
|
N/A | |
Completed |
NCT00174174 -
Provigil (Modafinil) Study by Taiwan Biotech Co.
|
N/A | |
Terminated |
NCT00750919 -
Twenty-six Week Extension Trial of Org 50081 (Esmirtazapine) in Outpatients With Chronic Primary Insomnia (176003/P05721/MK-8265-007)
|
Phase 3 | |
Completed |
NCT02939586 -
The Effect of Haemodialysis in Sleep Apnoea
|
N/A | |
Completed |
NCT03075241 -
Z-Drugs for Sleep Disorders in Alzheimer's Disease
|
Phase 3 | |
Completed |
NCT02585609 -
Sleep Quality in Patients With Advanced Cancer
|
N/A | |
Completed |
NCT03055156 -
Effect of High Rebound Mattress Toppers on Sleep and Sleep-Related Symptoms
|
N/A | |
Completed |
NCT01929447 -
Evaluation of WP200 With the Unified Probe (WP200U)
|
N/A | |
Completed |
NCT02156128 -
Subjective Memory Complaints, Objective Memory Performance and Cognitive Training
|
N/A | |
Completed |
NCT01906866 -
Efficacy and Safety of Circadin® in the Treatment of Sleep Disturbances in Children With Neurodevelopment Disabilities
|
Phase 3 | |
Completed |
NCT01528462 -
Sleep Disorders Managed and Assessed Rapidly in Transient Ischemic Attack (TIA) and In Early Stroke
|
||
Completed |
NCT01256983 -
Light for Renal Transplant Recipients Having a Sleep-Wake Dysregulation
|
Phase 0 | |
Completed |
NCT01220401 -
Efficacy of a Brief Nightmare Treatment for Veterans
|
N/A | |
Not yet recruiting |
NCT00749814 -
Sleep Disturbances in Hospitalized Children
|
Phase 4 | |
Completed |
NCT00518986 -
Efficacy and Safety of Armodafinil for Adults With Excessive Sleepiness Obstructive Sleep Apnea/Hypopnea and Depression
|
Phase 4 |